Konstanz/Germany based contract research organization Trenzyme GmbH and Basel/Switzerland based Celonic AG today announced the closure of a licence agreement on Celonics CHO-K1 based cell line expression platform SEFEX. Under the terms of the deal, Trenzyme acquires the non-exclusive rights and know-how on this technology to establish high performance cell lines for R&D and GMP production purposes for its clients.
The SErum Free EXpression technology,SEFEX, is a royalty-free cell li
CCAM (Eye)oT(TM) Technology Self-Adapts to Enable Scene-Dependent Data Compression, Dramatically Improving Speed, Dynamic Range and Power Efficiency for Vision-Enabled Applications
VANCOUVER, BRITISH COLUMBIA — (Marketwired) — 10/05/15 — Editors Note: There is a photo associated with this press release.Allocadia founders Kristine Steuart and Katherine Berry have been named among BC–s top entrepreneurs, executives and professionals in this year–s Business in Vancouver (BIV) Forty Under 40 awards.The BIV Forty Under 40 each year highlights the forty most outstanding people in business under the age of 40 throughout the province."I speak for the entire team at Allo
AMD LiquidVR(TM) Technology Recognized as a New Technology Driving the Creative Industry Forward by the Advanced Imaging Society, Representing Premier Hollywood Stakeholders
TORONTO, ONTARIO — (Marketwired) — 10/05/15 — BlueRush Media Group Corp. (TSX VENTURE: BTV) and Johns Hopkins announced that the Managing Cancer at Work program has received the prestigious Gold Award at the Digital Health awards.The Digital Health Awards recognize high-quality digital health resources for consumers and health professionals. The Digital Health Awards are an extension of the National Health Information Awards, the largest program of its kind in the United States."The Ma
